Spontaneous and Chemically-induced Bladder Cancer Animal Model
Investigations using animal model systems have been enlightening us with the biology underpinning the development of bladder cancer besides strengthening the existing therapy to improve the clinical outcome in patients. To date, spontaneous and chemical inductions are the classical methods in the generation of animal models of bladder cancer. Attributed to many benefits such as simple protocols and lower maintenance cost, these animal models are widely applied in the investigations of bladder cancer pathogenesis and screening of therapeutic drug. In this review, we give an overview of spontaneous- and chemically-induced bladder cancer animal models accompanying by the pros and cons of these two types of models. Furthermore, various chemical carcinogens used in the induction are discussed with the potential benefits and pitfalls in the establishment of animal models. This review will provide insightful information about the selection of the correct method in establishing the animal models of bladder cancer which are instrumental for studying potential therapeutic agents that target bladder cancer.
Jackson SJ, Thomas GJ, 2017, Human Tissue Models in Cancer Research: Looking Beyond the Mouse. Dis Model Mech, 10:939–42. DOI: 10.1242/dmm.031260.
Cekanova M, Rathore K, 2014, Animal Models and Therapeutic Molecular Targets of Cancer: Utility and Limitations. Drug Des Dev Ther, 8:1911–21. DOI: 10.2147/dddt.s49584.
Braida D, Ponzoni L, Matteoli M, et al., 2016, Different Attentional Abilities among Inbred Mice Strains Using Virtual Object Recognition Task (VORT): SNAP25+/− Mice as a Model of Attentional Deficit. Basic Clin Pharmacol Toxicol, 296:393–400. DOI: 10.1016/j.bbr.2015.08.016.
Ito H, Aizawa N, Fujita Y, et al., 2014, Long-Term Caloric Restriction in Rats May Prevent Age Related Impairment of In Vitro Bladder Function. J Urol, 193:2123–30. DOI: 10.1016/j.juro.2014.11.005.
Vasconcelos-Nóbrega C, Colaço A, Lopes C, et al., 2012, Review: BBN as an Urothelial Carcinogen. In Vivo, 26:727–39.
Ireson C, Alavijeh M, Palmer A, et al., 2019, The Role of Mouse Tumour Models in the Discovery and Development of Anticancer Drugs. Br J Cancer, 121:101–8. DOI: 10.1038/s41416-019-0495-5.
Yang Z, He L, Lin K, et al., 2017, The KMT1A-GATA3-STAT3 Circuit is a Novel Self-Renewal Signaling of Human Bladder Cancer Stem Cells. Clin Cancer Res, 23:6673–85. DOI: 10.1158/1078-0432.ccr-17-0882.
Marco V, Cerruto MA, D’Elia C, et al., 2014, Prognostic Role of Substaging in T1G3 Transitional Cell Carcinoma of the Urinary Bladder. Mol Clin Oncol, 2:575–80. DOI: 10.3892/mco.2014.290.
Katt M, Placone A, Wong A, et al., 2016, In Vitro Tumor Models: Advantages, Disadvantages, Variables, and Selecting the Right Platform. Front Bioeng Biotechnol, 4:12. DOI: 10.3389/fbioe.2016.00012.
Arantes-Rodrigues R, Colaço A, Pinto-Leite R, et al., 2013, In Vitro and In Vivo Experimental Models as Tools to Investigate the Efficacy of Antineoplastic Drugs on Urinary Bladder Cancer. Anticancer Res, 33:1273–96.
Rockwell S, 1980, In Vivo In Vitro Tumour Cell Lines: Characteristics and Limitations as Models for Human Cancer. Br J Cancer Suppl, 4:118–22.
Wancket L, 2015, Animal Models for Evaluation of Bone Implants and Devices: Comparative Bone Structure and Common Model Uses. Vet Pathol, 52:842–50. DOI: 10.1177/0300985815593124.
Degeorge K, Holt H, Hodges S, 2017, Bladder Cancer: Diagnosis and Treatment. Am Fam Physician, 96:507–14.
Siriwardena A, Samarji WN, 1993, Cutaneous Tumour Seeding from a Previously Undiagnosed Pancreatic Carcinoma after Laparoscopic Cholecystectomy. Ann R Coll Surg Engl, 75:199–200.
Li J, Zhang Z, Wang J, et al., 2014, Urinary Cytology with Acridine Orange Fluorescence is Highly Valuable for Predicting High-grade Upper Urinary Tract Urothelial Carcinoma. Int J Clin Exp Pathol, 2014;7:774–8.
Johnson AM, O’Connell MJ, Messing EM, et al., 2008, Decreased Bladder Cancer Growth in Parous Mice. Urology, 72:470–3. DOI: 10.1016/j.urology.2008.04.028.
Günther J, Frambach M, Deinert I, et al., 1999, Effects of Acetylic Salicylic Acid and Pentoxifylline on the Efficacy of Intravesical BCG Therapy in Orthotopic Murine Bladder Cancer (MB49). J Urol, 161:1702–6. DOI: 10.1016/s0022-5347(05)69008-8.
Hafeez S, Huddart R, 2013, Advances in Bladder Cancer Imaging. BMC Med, 11:104.
Patel AR, Chan ES, Hansel DE, et al, 2010, Transabdominal Micro-ultrasound Imaging of Bladder Cancer in a Mouse Model: A Validation Study. Urology, 75:799–804. DOI: 10.1016/j.urology.2009.06.047.
Glaser AP, Procissi D, Yu Y, et al., 2019, Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors. J Vis Exp, 145:e59101. DOI: 10.3791/59101.
Hewitt HB, 1978, The Choice of Animal Tumors for Experimental Studies of Cancer Therapy. Adv Cancer Res, 27:149–200.
Nolan M, Gieger T, Vaden S, 2015, Management of Transitional Cell Carcinoma of the Urinary Bladder in Dogs: Important Challenges to Consider. Vet J, 205:126–7. DOI: 10.1016/j.tvjl.2015.03.022.
Knapp D, Ramos-Vara JA, Moore GE, et al., 2014, Urinary bladder cancer in dogs, a naturally occurring model for cancer biology and drug development. ILAR J, 55:100–18. DOI: 10.1093/ilar/ilu018.
Maeda S, Tomiyasu H, Tsuboi M, et al., 2018, Comprehensive gene expression analysis of canine invasive urothelial bladder carcinoma by RNA-Seq. BMC Cancer, 18:472. DOI: 10.1186/s12885-018-4409-3.
Drago JR, Nesbitt JA, 1987, NB Rat Bladder Cancer Model: Evaluation of the Subrenal Capsular Assay System. J Surg Oncol, 36:5–7. DOI: 10.1002/jso.2930360103.
van Moorselaar RJ, Ichikawa T, Schaafsma HE, et al., 1993, The Rat Bladder Tumor Model System RBT Resembles Phenotypically and Cytogenetically Human Superficial Transitional Cell Carcinoma. Urol Res, 21:413–21. DOI: 10.1007/bf00300078.
Druckrey H, Preussmann R, Ivankovic S, et al.,1964, Selective Induction of Bladder Cancer in Rats by Dibutyl and n-Butyl-n-Butanol(4)-Nitrosamine. Z Krebsforsch, 66:280–90.
Ertürk E, Price JM, Morris JE, et al., 1967, The Production of Carcinoma of the Urinary Bladder in Rats by Feeding N-[4-(5-Nitro-2-furyl)-2-thiazolyl]formamide. Cancer Res, 27:1998–2002.
Hicks R, Wakefield J, 1972, Rapid Induction of Bladder Cancer in Rats with TV-methyl-N-Nitrosurea. 1. Histology. Chem Biol Interact, 5:139–52.
Cohen S, 2002, Comparative Pathology of Proliferative Lesions of the Urinary Bladder. Toxicol Pathol, 30:663–71. DOI: 10.1080/01926230290166751.
Gomes-Giacoia E, Miyake M, Goodison S, et al., 2014, Intravesical ALT-803 and BCG Treatment Reduces Tumor Burden in a Carcinogen Induced Bladder Cancer Rat Model; a Role for Cytokine Production and NK Cell Expansion. PLoS One, 9:e96705. DOI: 10.1371/journal.pone.0096705.
He Z, Kosinska W, Zhao ZL, et al., 2012, Tissue-specific Mutagenesis by N-butyl-N-(4-Hydroxybutyl)Nitrosamine as the Basis for Urothelial Carcinogenesis. Mutat Res, 742:92–5. DOI: 10.1016/j.mrgentox.2011.11.015.
Fantini D, Glaser AP, Rimar KJ, et al., 2018, A Carcinogen-induced Mouse Model Recapitulates the Molecular Alterations of Human Muscle Invasive Bladder Cancer. Oncogene, 37:1911–25. DOI: 10.1158/1538-7445.mousemodels17-b29.
Arum CJ, Kodama Y, Rolim N, et al., 2010, A rat model of intravesical delivery of small interfering RNA for studying urinary carcinoma. World J Urol, 28:479–85. DOI: 10.1007/s00345-010-0542-6.
Holmäng S, Cano M, Grenabo L, et al., 1995, Effect of Indomethacin on N-[4-(5-nitro-2-furyl)-2-thiazolyl]Formamide-Induced Urinary Tract Carcinogenesis. Carcinogenesis, 16:1493–8. DOI: 10.1093/carcin/16.7.1493.
Ferrari K, de Camargo JA, Rocha GZ, et al., 2014, Intravesical Bacillus Calmette-Guérin Efficiently Reduces p70S6K1 but Not 4E-BP1 Phosphorylation in Nonmuscle Invasive Bladder Cancer. J Urol, 193:682–9. DOI: 10.1016/j.juro.2014.08.106.
Li J, Qu W, Cheng Y, et al., 2014, The Inhibitory Effect of Intravesical Fisetin against Bladder Cancer by Induction of p53 and Down-Regulation of NF-kappa B Pathways in a Rat Bladder Carcinogenesis Model. Basic Clin Pharmacol Toxicol, 115:321–9. DOI: 10.1111/bcpt.12229.
Nakanishi K, Hagiwara A, Shibata M, et al., 1980, Dose Response of Saccharin in Induction of Urinary Bladder Hyperplasias in Fischer 344 Rats Pretreated with N-butyl-N-(4-Hydroxybutyl)Nitrosamine. J Natl Cancer Inst, 65:1005–10. DOI: 10.1093/jnci/65.5.1005.
Cohen SM, Aral M, Jacobs JB, et al., 1979, Promoting Effect of Saccharin and DL-Tryptophan in Urinary Bladder Carcinogenesis. Cancer Res, 39:1207.
Tsuda H, Sakata T, Shirai T, et al., 1984, Modification of N-methyl-N-Nitrosourea Initiated Carcinogenesis in the Rat by Subsequent Treatment with Antioxidants, Phenobarbital and Ethinyl Estradiol. Cancer Lett, 24:19–27. DOI: 10.1016/0304-3835(84)90075-2.
Tsuda H, Fukushima S, Imaida K, et al., 1983, Organ-specific Promoting Effect of Phenobarbital and Saccharin in Induction of Thyroid, Liver, and Urinary Bladder Tumors in Rats after Initiation with N-Nitrosomethylurea. Cancer Res, 43:3292–6.
Ito N, Hirose M, Shibata M, et al., 1989, Modifying Effects of Simultaneous Treatment with Butylated Hydroxyanisole (BHA) on Rat Tumor Induction by 3,2’-Dimethyl-4-Aminobiphenyl, 2,2’-Dihydroxy-di-n-Propylnitrosamine and N-Methylnitrosourea. Carcinogenesis, 10:2255–9. DOI: 10.1093/carcin/10.12.2255.
Kawai K, Kawamata H, Kameyama S, et al., 1995, Intraluminal Epidermal Growth Factor affects Growth of N-methyl-N-Nitrosourea-Initiated Rat Bladder Carcinoma. Jpn J Cancer Res, 86:429–34. DOI: 10.1111/j.1349-7006.1995.tb03075.x.
Ibrahiem EH, Nigam VN, Brailovsky CA, et al., 1983, Orthotopic Implantation of Primary N-[4-(5-Nitro-2-furyl)-2-thiazolyl]Formamide-Induced Bladder Cancer in Bladder Submucosa: An Animal Model for Bladder Cancer Study. Cancer Res, 43:617–22. DOI: 10.1016/0304-3835(94)90366-2.
Kiel H, Adolphs HD, Thiele J, et al., 1978, Biological Behavior of N-[4-(5-nitro-2-furyl)-2-thiazolyl]-Formamide Induced Carcinoma of the Transitional Epithelium in the Rat. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol, 91:267–77. DOI: 10.1007/bf00312289.